InsiderSignal.AI

InsiderSignal.ai

HRTX - Heron Therapeutics, Inc. /De/

Insider Purchase by Rubric Capital Management LP (10%)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Rubric Capital Management LP, serving as 10% owner at Heron Therapeutics, Inc. /De/ (HRTX), purchased 2,387,225 shares at $1.50 per share, for a total transaction value of $3,580,838.00. Following this transaction, Rubric Capital Management LP now holds 29,100,728 shares of HRTX.

This purchase represents a 9.00% increase in Rubric Capital Management LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 8, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 12, 2025, 4 days after the trade was made.

Heron Therapeutics, Inc. /De/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Rubric Capital Management LP

10%

Rubric Capital Management LP is a New York-based hedge fund founded in 2016 by David Rosen, specializing in multi-strategy, opportunistic investments primarily in public equities with a research-driven, value-focused approach.[[1]](https://fintool.com/app/research/funds/hedge-funds/rubric-capital-management-lp)[[3]](https://radientanalytics.com/firm/adv/rubric-capital-management-lp-285090)[[6]](https://www.preqin.com/data/profile/fund-manager/rubric-capital-management/191163) The firm, registered as an investment adviser, manages discretionary strategies for pooled vehicles, serving institutional clients, funds, and high-net-worth individuals, employing about 14 professionals and headquartered at 155 East 44th Street, Suite 1630.[[1]](https://fintool.com/app/research/funds/hedge-funds/rubric-capital-management-lp)[[4]](https://www.zoominfo.com/c/rubric-capital-management-lp/436405534)[[5]](https://www.sec.gov/Archives/edgar/data/1685924/000090266424005626/xslFormDX01/primary_doc.xml) Rubric takes concentrated long and short positions across sectors like healthcare and energy, with its Q2 2025 13F filing reporting 62 equity positions and 3 options positions totaling $7 billion in market value, including top holding Talen Energy Corp (19.79% weight).[[1]](https://fintool.com/app/research/funds/hedge-funds/rubric-capital-management-lp) As a corporate insider, it has served as a 10% owner in companies such as Talen Energy Corp (TLN), Radius Health Inc (RDUS), TherapeuticsMD Inc (TXMD), and recently Heron Therapeutics, Inc. (HRTX), alongside activist involvement like nominating directors at Xperi Inc.[[2]](https://www.gurufocus.com/insider/171786/rubric-capital-management-lp)[[4]](https://www.zoominfo.com/c/rubric-capital-management-lp/436405534)

View full insider profile →

Trade Price

$1.50

Quantity

2,387,225

Total Value

$3,580,838.00

Shares Owned

29,100,728

Trade Date

Friday, August 8, 2025

198 days ago

SEC Filing Date

Tuesday, August 12, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Heron Therapeutics, Inc. /De/

Company Overview

No company information available
View news mentioning HRTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/123423

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime